
    
      Participants consenting to participate in this study will be asked to complete study
      questionnaires by phone interviews upon consenting (Baseline), and up to 12 months following
      treatment initiation with asfotase alfa. Demographic and clinical characteristics of
      participants in the study will be characterized.

      This is an observational study and no intervention will be administered. Participants will be
      treated in accordance with standard of care.
    
  